COST-CONSEQUENCE ANALYSIS COMPARING ROMIPLOSTIM TO RITUXIMAB IN THE TREATMENT OF ADULT PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN GERMANY

被引：0
|
作者：
von Depka, M. [1 ]
Salama, A. [2 ]
Perrin, A. [3 ]
Oelze, I. [3 ]
Chulikavit, M. [3 ]
Kunz, E. [4 ]
Kutikova, L. [4 ]
Thalheimer, M. [5 ]
机构：
[1] Werlhof Inst, Hannover, Germany
[2] Charite Univ Med Berlin, Inst Transfus Med, Berlin, Germany
[3] Analyt LA SER Int Inc, New York, NY USA
[4] Amgen GmbH, Munich, Germany
[5] Univ Klinikum Heidelberg, Heidelberg, Germany
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1045
引用
收藏
页码：427 / 427
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF ROMIPLOSTIM AS FIRST-LINE PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) TREATMENT IN ADULT SPLENECTOMISED PATIENTS WHO ARE REFRACTORY TO OTHER TREATMENTS AND AS SECOND-LINE ITP TREATMENT IN ADULT NON-SPLENECTOMISED PATIENTS WHERE SURGERY IS CONTRAINDICATED IN COLOMBIA
    Vargas-Valencia, J.
    Garcia Perlaza, J.
    VALUE IN HEALTH, 2015, 18 (07) : A842 - A842
  • [42] SAFETY ANALYSIS OF LONG-TERM ROMIPLOSTIM USE IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)
    Rodeghiero, F.
    Provan, D.
    Cines, D.
    Stasi, R.
    Tarantino, M.
    Nie, K.
    Jun, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 73 - 74
  • [43] Analysis of Mortality Rates During Romiplostim Clinical Studies of Patients (Pts) with Immune Thrombocytopenia (ITP)
    Gernsheimer, Terry
    Kuter, David J.
    Cines, Douglas B.
    Stasi, Roberto
    Rummel, Mathias J.
    Godeau, Bertrand
    Guo, Matthew
    Franklin, Janet
    BLOOD, 2010, 116 (21) : 1518 - 1519
  • [44] Pooled Analysis of Safety and Efficacy of Romiplostim in Splenectomized and Nonsplenectomized Patients (pts) with Immune Thrombocytopenia (ITP)
    Rodeghiero, Francesco
    Provan, Andrew
    Steurer, Michael
    Godeau, Bertrand
    Carpenter, Nancy
    Kreuzbauer, Georg
    BLOOD, 2014, 124 (21)
  • [45] LONG TERM FOLLOW UP ANALYSIS FOLLOWING RITUXIMAB SALVAGE THERAPY IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Zaja, F.
    Volpetti, S.
    Chiozzotto, M.
    Puglisi, S.
    Isola, M.
    Fanin, R.
    HAEMATOLOGICA, 2012, 97 : 429 - 429
  • [46] Evolution of platelet function in adult patients with chronic immune thrombocytopenia on romiplostim treatment
    Ignatova, Anastasia A.
    Demina, Irina A.
    Ptushkin, Vadim V.
    Khaspekova, Svetlana G.
    Shustova, Olga N.
    Pankrashkina, Maria M.
    Ryabykh, Aleksandr A.
    Obydennyi, Sergei I.
    Strelkova, Olga S.
    Polokhov, Dmitry M.
    Seregina, Elena A.
    Poletaev, Aleksandr V.
    Ataullakhanov, Fazoil I.
    Kireev, Igor I.
    Mazurov, Alexei V.
    Maschan, Alexei A.
    Novichkova, Galina A.
    Panteleev, Mikhail A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (02) : E38 - E42
  • [47] DETERMINING THE COST OF A BLEEDING-RELATED EPISODE IN PRIMARY ADULT CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN THE UNITED STATES
    Northridge, K.
    Danese, M.
    Deuson, R.
    VALUE IN HEALTH, 2013, 16 (03) : A117 - A117
  • [48] THE HOSPITALIZATION NEED AND COST OF ADULT PRIMARY IMMUNE THROMBOCYTOPENIA TREATMENT: A MONOCENTRIC EVALUATION
    Ruggeri, M.
    Fortuna, S. F.
    Rodeghiero, F. R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 91 - 91
  • [49] Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice - Interim Results From a Large, European, Observational Study
    Selleslag, Dominik
    Janssens, Ann
    Wadenvik, Hans
    Steurer, Michael
    Quittet, Philippe
    Kaiafa, Georgia
    Kozak, Tomas
    Papadaki, Helen
    Viallard, Jean-Francois
    Dillingham, Kerry
    Kreuzbauer, Georg
    BLOOD, 2012, 120 (21)
  • [50] ROMIPLOSTIM FOR THE TREATMENT OF ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ROUTINE CLINICAL PRACTICE - INTERIM RESULTS FROM A LARGE, EUROPEAN, OBSERVATIONAL STUDY
    Wadenvik, H.
    Steurer, M.
    Janssens, A.
    Quittet, P.
    Kaiafa, G.
    Kozak, T.
    Papadaki, H.
    Selleslag, D.
    Dillingham, K.
    Kreuzbauer, G.
    HAEMATOLOGICA, 2012, 97 : 252 - 252
12345